720
Participants
Start Date
July 25, 2023
Primary Completion Date
February 28, 2025
Study Completion Date
July 31, 2025
Non-Interventional
Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.
Non-Interventional Follow-up
Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.
Weill Cornell Medicine - Cornell Clinical Trials Unit, New York
Mount Sinai Hospital, New York
Montefiore Medical Center, The Bronx
Abramson Cancer Center at Pennsylvania Hospital, Philadelphia
George Washington University Cancer Center, Washington D.C.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Moffitt Cancer Center, Tampa
The Ohio State University, Columbus
University of Illinois at Chicago, Chicago
Washington University School of Medicine, St Louis
MD Anderson Cancer Center, Houston
Huntsman Cancer Institute - University of Utah, Salt Lake City
Moores UCSD Cancer Center, La Jolla
Virginia Mason Medical Center, Seattle
University of Puerto Rico, San Juan
National Cancer Institute (NCI)
NIH
AIDS Malignancy Consortium
NETWORK